These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34463762)

  • 21. No pain, no gain: an exploratory within-subjects mixed-methods evaluation of the patient experience of sleep restriction therapy (SRT) for insomnia.
    Kyle SD; Morgan K; Spiegelhalder K; Espie CA
    Sleep Med; 2011 Sep; 12(8):735-47. PubMed ID: 21907616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Armodafinil to reduce the sleepiness related side-effects of sleep restriction therapy being used to treat insomnia disorder: An open label clinical trial pilot study compared with historical controls.
    Judge DJ; Miller CB; Bartlett DJ; Jomaa I; Wong KKW; Saini B; Semsarian CR; Espie CA; Kyle SD; Grunstein RR; Yee BJ; Marshall NS
    J Sleep Res; 2023 Feb; 32(1):e13699. PubMed ID: 36003019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased high-frequency NREM EEG power associated with mindfulness-based interventions for chronic insomnia: Preliminary findings from spectral analysis.
    Goldstein MR; Turner AD; Dawson SC; Segal ZV; Shapiro SL; Wyatt JK; Manber R; Sholtes D; Ong JC
    J Psychosom Res; 2019 May; 120():12-19. PubMed ID: 30929703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EEG spectral analysis in primary insomnia: NREM period effects and sex differences.
    Buysse DJ; Germain A; Hall ML; Moul DE; Nofzinger EA; Begley A; Ehlers CL; Thompson W; Kupfer DJ
    Sleep; 2008 Dec; 31(12):1673-82. PubMed ID: 19090323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychomotor performance deficits and their relation to prior nights' sleep among individuals with primary insomnia.
    Edinger JD; Means MK; Carney CE; Krystal AD
    Sleep; 2008 May; 31(5):599-607. PubMed ID: 18517030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of trazodone versus cognitive-behavioural treatment on high- and slow-frequency activity during non-rapid eye movement sleep in chronic insomnia: A pilot, randomized clinical trial.
    Li Y; Vgontzas AN; Fernandez-Mendoza J; Fang J; Puzino K; Bixler EO
    J Sleep Res; 2021 Oct; 30(5):e13324. PubMed ID: 33675113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial.
    Dauvilliers Y; Verbraecken J; Partinen M; Hedner J; Saaresranta T; Georgiev O; Tiholov R; Lecomte I; Tamisier R; Lévy P; Scart-Gres C; Lecomte JM; Schwartz JC; Pépin JL;
    Am J Respir Crit Care Med; 2020 May; 201(9):1135-1145. PubMed ID: 31917607
    [No Abstract]   [Full Text] [Related]  

  • 29. A Meditation Based Cognitive Therapy (HMBCT) for Primary Insomnia: A Treatment Feasibility Pilot Study.
    Behera CK; Reddy TK; Behera L; Birbaumer N; Ika K
    Appl Psychophysiol Biofeedback; 2023 Sep; 48(3):369-378. PubMed ID: 37103669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of group treatment for insomnia on daytime symptomatology: Analyses from a randomized controlled trial in primary care.
    Sandlund C; Hetta J; Nilsson GH; Ekstedt M; Westman J
    Int J Nurs Stud; 2018 Sep; 85():126-135. PubMed ID: 29886347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Objective sleep disturbance is associated with poor response to cognitive and behavioral treatments for insomnia in postmenopausal women.
    Kalmbach DA; Cheng P; Roth T; Sagong C; Drake CL
    Sleep Med; 2020 Sep; 73():82-92. PubMed ID: 32799029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive Behavioral Therapy for Insomnia in Older Veterans Using Nonclinician Sleep Coaches: Randomized Controlled Trial.
    Alessi C; Martin JL; Fiorentino L; Fung CH; Dzierzewski JM; Rodriguez Tapia JC; Song Y; Josephson K; Jouldjian S; Mitchell MN
    J Am Geriatr Soc; 2016 Sep; 64(9):1830-8. PubMed ID: 27550552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The interaction between stress and sleep disorders among foreign medical students in Georgia.
    Sakhelashvili I; Spruyt K
    Sleep Med; 2023 Oct; 110():225-230. PubMed ID: 37647713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combining mindfulness meditation with cognitive-behavior therapy for insomnia: a treatment-development study.
    Ong JC; Shapiro SL; Manber R
    Behav Ther; 2008 Jun; 39(2):171-82. PubMed ID: 18502250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of Cognitive-Behavioural Therapy (CBT) as related to sleep quality and hyperarousal level in the treatment of primary insomnia.
    Gałuszko-Węgielnik M; Jakuszkowiak-Wojten K; Wiglusz MS; Cubała WJ; Landowski J
    Psychiatr Danub; 2012 Sep; 24 Suppl 1():S51-5. PubMed ID: 22945187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The increase in longitudinally measured sleepiness across adolescence is related to the maturational decline in low-frequency EEG power.
    Campbell IG; Higgins LM; Trinidad JM; Richardson P; Feinberg I
    Sleep; 2007 Dec; 30(12):1677-87. PubMed ID: 18246977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical effects of sleep restriction therapy for insomnia: A meta-analysis of randomised controlled trials.
    Maurer LF; Schneider J; Miller CB; Espie CA; Kyle SD
    Sleep Med Rev; 2021 Aug; 58():101493. PubMed ID: 33984745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized Controlled Pilot Trial of Behavioral Insomnia Treatment for Chronic Migraine With Comorbid Insomnia.
    Smitherman TA; Walters AB; Davis RE; Ambrose CE; Roland M; Houle TT; Rains JC
    Headache; 2016 Feb; 56(2):276-91. PubMed ID: 26813845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.